U.S. Approves First At-Home Test Kit for Detecting Covid-19
- Lucira Health assay can be processed in 30 minutes for $50
- Harvard epidemiologist says test will have limited value
This article is for subscribers only.
The U.S. gave a green light to the first Covid-19 testing kit to be used in the home, adding a new tool to battle the pandemic as nationwide testing capabilities come under more strain.
The Food and Drug Administration issued an emergency use authorization to Lucira Health Inc.’s rapid-result All-In-One Test Kit, according to a statement from the agency on Tuesday. The kit is expected to cost around $50, the company said, and consumers will need a prescription to acquire it.